Agilent Technologies Reports Second Quarter 2009 Results

Considering the very difficult macroeconomic environment, Bio-Analytical Measurement performed well in the second quarter. Orders of $481 million were down 16 percent from one year earlier, while revenues of $498 million were off 6 percent from last year. During the quarter, Chemical Analysis was down 6 percent, while Life Sciences revenues were off 7 percent.

Geographically, weakness was most pronounced in Europe, which was off 16 percent from last year, while revenue in the Americas was off 10 percent. Asia remained an area of strength, with Japan up 7 percent from last year and other Asia up 12 percent. China was particularly robust, up 29 percent from one year ago. By product platform, Gas (GC) and Liquid Chromatography (LC) were both weak, offsetting continued strength in GC / Mass Spectrometry (GC/MS), LC/MS and microarrays.

Life Sciences revenues of $241 million were down 7 percent in the second quarter from one year ago. Spending by Pharma and Biotech customers was down 11 percent, with a lengthening of the replacement cycle in the current soft environment and funding pressures impacting smaller biotech firms. Sales to the academic and government markets continued strong, 10 percent above one year ago, with robust demand in Mass Spec systems as well as for microarrays.

Chemical Analysis revenues of $257 million were down 6 percent from last year. Food safety continued its strong momentum and was up 30 percent from one year ago, while weakness was seen across most industrial markets. From a platform perspective, demand remained weak for GCs and relatively strong for GC/MS and LC/MS systems.

Second quarter segment income from operations of $89 million was $4 million above last year’s results despite a $32 million decline in revenues. Gross margins were up 1 ½ points from last year, while operating margins, at 18 percent, were two points above one year ago. Segment Return On Invested Capital(2) improved 2 points to 24 percent.

Electronic Measurement
($ millions except where noted)
  Q2:F09   Q1:F09   Q2:F08
Orders 523 560 863
Revenues 558 596 831
Gross Margin, % 52 % 55 % 59 %
Income from Operations (6 ) 7 120
Segment Assets 1,859 1,920 2,083
Return On Invested Capital (2) , % (1 %) 3 % 28 %

« Previous Page 1 | 2 | 3 | 4 | 5 | 6  Next Page »



Review Article Be the first to review this article

EMA:

Featured Video
Editorial
Peggy AycinenaWhat Would Joe Do?
by Peggy Aycinena
Retail Therapy: Jump starting Black Friday
Peggy AycinenaIP Showcase
by Peggy Aycinena
REUSE 2016: Addressing the Four Freedoms
More Editorial  
Jobs
Development Engineer-WEB SKILLS +++ for EDA Careers at North Valley, CA
Principal Circuit Design Engineer for Rambus at Sunnyvale, CA
ACCOUNT MANAGER MUNICH GERMANY EU for EDA Careers at MUNICH, Germany
Manager, Field Applications Engineering for Real Intent at Sunnyvale, CA
Upcoming Events
Zuken Innovation World 2017, April 24 - 26, 2017, Hilton Head Marriott Resort & Spa in Hilton Head Island, SC at Hilton Head Marriott Resort & Spa Hilton Head Island NC - Apr 24 - 26, 2017
CST Webinar Series



Internet Business Systems © 2016 Internet Business Systems, Inc.
595 Millich Dr., Suite 216, Campbell, CA 95008
+1 (408)-337-6870 — Contact Us, or visit our other sites:
AECCafe - Architectural Design and Engineering TechJobsCafe - Technical Jobs and Resumes GISCafe - Geographical Information Services  MCADCafe - Mechanical Design and Engineering ShareCG - Share Computer Graphic (CG) Animation, 3D Art and 3D Models
  Privacy Policy